FDA issues final guidance on insanitary conditions for compounding facilities

The Food and Drug Administration this week released final guidance for pharmacies, federal facilities and outsourcing facilities that compound or repackage drugs or mix, dilute or repackage biological products. The guidance provides examples of insanitary conditions under the Federal Food, Drug and Cosmetic Act, and recommended actions to prevent or correct insanitary conditions in compounding facilities.